Sabrina Mariotti

Dr. Sabrina Mariotti

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
RNRoberto Nisini
Roberto Nisini
Noemi PoerioNoemi Poerio
Noemi Poerio
SMSabrina Mariotti
Sabrina Mariotti
FSFederica De Santis
Federica De Santis
MFM Fraziano
M Fraziano
Liposomes are closed bilayer structures spontaneously formed by hydrated phospholipids that are widely used as efficient delivery systems for drugs or antigens, due to their capability to encapsulate bioactive hydrophilic, amphipathic, and lipophilic molecules into inner water phase or within lipid leaflets. The efficacy of liposomes as drug or antigen carriers has been improved in the last years to ameliorate pharmacokinetics and capacity to release their cargo in selected target organs or cells. Moreover, different formulations and variations in liposome composition have been often proposed to include immunostimulatory molecules, ligands for specific receptors, or stimuli responsive compounds. Intriguingly, independent research has unveiled the capacity of several phospholipids to play critical roles as intracellular messengers in modulating both innate and adaptive immune responses through various mechanisms, including (i) activation of different antimicrobial enzymatic pathways, (ii) driving the fusion–fission events between endosomes with direct consequences to phagosome maturation and/or to antigen presentation pathway, and (iii) modulation of the inflammatory response. These features can be exploited by including selected bioactive phospholipids in the bilayer scaffold of liposomes. This would represent an important step forward since drug or antigen carrying liposomes could be engineered to simultaneously activate different signal transduction pathways and target specific cells or tissues to induce antigen-specific T and/or B cell response. This lipid-based host-directed strategy can provide a focused antimicrobial innate and adaptive immune response against specific pathogens and offer a novel prophylactic or therapeutic option against chronic, recurrent, or drug-resistant infections.

23 February 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MGMartine NICOLE Gilleron
Martine NICOLE Gilleron
SSSteffen Stenger
Steffen Stenger
ZMZaima Mazorra
Zaima Mazorra
FWFrederick Wittke
Frederick Wittke
SMSabrina Mariotti
Sabrina Mariotti
GLGennaro De Libero
Gennaro De Libero
Mycobacterial lipids comprise a heterogeneous group of molecules capable of inducing T cell responses in humans. To identify novel antigenic lipids and increase our understanding of lipid-mediated immune responses, we established a panel of T cell clones with different lipid specificities. Using this approach we characterized a novel lipid antigen belonging to the group of diacylated sulfoglycolipids purified from Mycobacterium tuberculosis. The structure of this sulfoglycolipid was identified as 2-palmitoyl or 2-stearoyl-3-hydroxyphthioceranoyl-2′-sulfate-α-α′-d-trehalose (Ac2SGL). Its immunogenicity is dependent on the presence of the sulfate group and of the two fatty acids. Ac2SGL is mainly presented by CD1b molecules after internalization in a cellular compartment with low pH. Ac2SGL-specific T cells release interferon γ, efficiently recognize M. tuberculosis–infected cells, and kill intracellular bacteria. The presence of Ac2SGL-responsive T cells in vivo is strictly dependent on previous contact with M. tuberculosis, but independent from the development of clinically overt disease. These properties identify Ac2SGL as a promising candidate to be tested in novel vaccines against tuberculosis.

25 November 2005 in Science
Verified
Journal Article
Closed access
PDF file
HSHenri de la Salle
Henri de la Salle
SMSabrina Mariotti
Sabrina Mariotti
CACatherine Angenieux
Catherine Angenieux
MGMartine NICOLE Gilleron
Martine NICOLE Gilleron
LGLuis-Fernando Garcia-Alles
Luis-Fernando Garcia-Alles
GLGennaro De Libero
Gennaro De Libero
Complexes between CD1 molecules and self or microbial glycolipids represent important immunogenic ligands for specific subsets of T cells. However, the function of one of the CD1 family members, CD1e, has yet to be determined. Here, we show that the mycobacterial antigens hexamannosylated phosphatidyl- myo -inositols (PIM 6 ) stimulate CD1b-restricted T cells only after partial digestion of the oligomannose moiety by lysosomal α-mannosidase and that soluble CD1e is required for this processing. Furthermore, recombinant CD1e was able to bind glycolipids and assist in the digestion of PIM 6 . We propose that, through this form of glycolipid editing, CD1e helps expand the repertoire of glycolipidic T cell antigens to optimize antimicrobial immune responses.

1 January 2009 in Chemistry & Biology
Verified
Journal Article
Closed access
ELEmilie Layre
Emilie Layre
ACAnthony Collmann
Anthony Collmann
MBMax Bastian
Max Bastian
SMSabrina Mariotti
Sabrina Mariotti
JCJerzy Czaplicki
Jerzy Czaplicki
MGMartine NICOLE Gilleron
Martine NICOLE Gilleron

1 August 2010 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
PDF file
RBR. Biselli
R. Biselli
SMSabrina Mariotti
Sabrina Mariotti
VSV. Sargentini
V. Sargentini
ISI. Sauzullo
I. Sauzullo
MLM. Lastilla
M. Lastilla
RNRoberto Nisini
Roberto Nisini

23 June 2009 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
VSValeria Sargentini
Valeria Sargentini
SMSabrina Mariotti
Sabrina Mariotti
SCStefania Carrara
Stefania Carrara
MGMaria Cristina Gagliardi
Maria Cristina Gagliardi
RTRaffaela Teloni
Raffaela Teloni
RNRoberto Nisini
Roberto Nisini
Background: The purpose of this study was to further characterize the immune response toMycobacterium tuberculosis(Mtb) antigens, in order to provide new insight into host-pathogen interactions in tuberculosis (TB), and to offer tools for a more accurate diagnosis of the different stages of TB.Methods: T-cell responses to Bacillus Calmette-Guérin (BCG), purified protein derivative (PPD), early secretory antigenic target-6 (ESAT-6) protein and culture filtrate protein-10 kDa (CFP-10) were measured in terms of interferon (IFN)-γ and interleukin (IL)-2 release, using a novel flow cytometric cell-secreting cytokine detection technique. The study was conducted on peripheral blood mononuclear cells (PBMC) obtained from active TB patients, latently TB infected individuals, and healthy donors. IL-10 and IL-17 were also measured to test their possible role as indicators of disease activity.Results: We confirmed that the enumeration of IFN-γ releasing cells upon Mtb-specific stimulation is sufficient to identify TB patients and that CD8+ T cells concur to IFN-γ secretion. IL-2 secreting cells were more frequently observed in latent TB infected individuals compared to active TB patients, suggesting that measurement of cells secreting this cytokine could be a marker of disease stage. No discriminating role was associated to IL-10 and IL-17 release in TB patients.Conclusion: Our data indicate that the flow cytometric cytokine-secreting cell detection technique may be envisaged as an additional tool for TB diagnosis allowing the analysis of the immune response toM. tuberculosis-related antigens in the different stages of TB.